Etiopathogenesis of hepatic osteodystrophy in wistar rats with cholestatic liver disease

Calcified Tissue International

Volumn 85, Issue 1, 2009, Pages 75-83

  Pereira, F A ^a   Facincani, Inalda ^a   Jorgetti, Vanda ^a   Ramalho, Leandra N Z ^a   Volpon, José B ^a   Dos Reis, Luciene M ^a   De Paula, Francisco J A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone histomorphometry; Hepatic osteodystrophy; IGF I; Osteomalacia; Osteoporosis

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BILE DUCT LIGATION; BIOMECHANICS; BLOOD LEVEL; BONE MINERALIZATION; BONE STRENGTH; CANCELLOUS BONE; CARTILAGE; CONTROLLED STUDY; FEMUR FRACTURE; FORCE; GENE EXPRESSION; GROWTH PLATE; HEPATIC OSTEODYSTROPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLESTASIS; MALE; MORPHOMETRICS; NONHUMAN; OSTEODYSTROPHY; OSTEOPOROSIS; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TIBIA;

ANIMALS; BONE DISEASES, METABOLIC; CHOLESTASIS, EXTRAHEPATIC; DISEASE MODELS, ANIMAL; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LIVER; LIVER DISEASES; MALE; RATS; RATS, WISTAR; TIBIA;

EID: 67651236721     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-009-9249-3     Document Type: Article

References (50)

1. AT de Albuquerque Taveira MI Fernandes LC Galvão R Sawamura E de Mello Vieira FJ de Paula 2007 Impairment of bone mass development in children with chronic cholestatic liver disease Clin Endocrinol 66 518 523
2. SF Hodgson ER Dickson HW Wahner KA Johnson KG Mann BL Riggs 1985 Bone loss and reduced osteoblast function in primary biliary cirrhosis Ann Intern Med 103 855 860
3. AJ Stellon A Webb J Compston R Williams 1986 Lack of osteomalacia in chronic cholestatic liver disease Bone 7 181 185
4. HF Herlong RR Recker WC Maddrey 1982 Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D Gastroenterology 83 103 108
5. H Rosen 1995 Primary biliary cirrhosis and bone disease Hepatology 21 253 255
6. SW van der Merwe MM Conradie R Bond BJ Olivier E Fritz M Nieuwoudt R Delport T Slavik G Engelbrecht D Kahn EG Shephard MJ Kotze NP de Villiers S Hough 2006 Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting World J Gastroenterol 12 4504 4510
7. F Szalay D Hegedus PL Lakatos I Tornai E Bajnok K Dunkel P Lakatos 2003 High serum osteoprotegerin and low RANKL in primary biliary cirrosis J Hepatol 38 395 400
8. RG Long E Meinhard RK Skinner Z Varghese MR Wills S Sherlock 1978 Clinical, biochemical and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease Gut 19 85 90
9. JE Compston RP Thompson 1977 Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis Lancet 1 721 724
10. JS Reed SC Meredith BA Nemchausky IH Rosenberg JL Boyer 1980 Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D Gastroenterology 78 512 517
11. TH Diamond D Stiel M Lunzer D McDowall RP Eckstein S Posen 1989 Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease Gastroenterology 96 213 221
12. N Guañabens A Parés L Mariñoso A Brancós C Piera S Serrano F Rivera J Rodés 1990 Factors influencing the development of metabolic bone disease in primary biliary cirrhosis Am J Gastroenterol 85 1356 1362
13. J Collier 2007 Bone disorders in chronic liver disease Hepatology 46 1271 1278
14. JA Cuthbert CYC Pak JE Zerwekh KD Glass B Combes 1984 Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia Hepatology 4 1 8
15. MS Shih C Anderson 1987 Does "hepatic osteodystrophy" differ from peri- and postmenopausal osteoporosis? A histomorphometric study Calcif Tissue Int 41 187 191
16. Z Ackerman M Weinerb G Amir RD Pollak 2002 Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease Liver 22 166 172
17. M Weinreb RD Pollak Z Ackerman 2004 Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis J Hepatol 40 385 390
18. FJ de Paula MB Góis-Júnior MH Aguiar-Oliveira A Pereira Fde CR Oliveira RM Pereira CT Farias TA Vicente R Salvatori 2009 Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene Clin Endocrinol 70 35 40
19. S Yakar CJ Rosen WG Beamer CL Arkert-Bickenell Y Wu JL Liu GT Ooi J Setser J Frystyk YR Boisclair D LeRoith 2002 Circulating levels of IGF-I directly regulate bone growth and density J Clin Invest 110 771 781
20. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 595 610
21. MC Lebrethon A Aganina M Fournier A Gérard AS Parent JP Bourguignon 2007 Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty J Neuroendocrinol 19 181 188
22. JA Horton JT Bariteau RM Loomis JA Strauss TA Damron 2008 Ontogeny of skeletal maturation in the juvenile rat Anat Rec 291 283 292
23. R Dresner-Pollak Y Gabet A Steimatzky G Hamdani I Bab Z Ackerman M Weinreb 2008 Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats Gastroenterology 134 259 267
24. CH Janes ER Dickson R Okazaki S Bonde AE McDonagh BL Riggs 1995 Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice J Clin Invest 95 2581 2586
25. SW van der Merwe JB van den Bogaerde C Goosen FF Maree RJ Milner CM Schnitzler A Biscardi JM Mesquita G Engelbrecht D Kahn J Fevery 2003 Hepatic osteodystrophy in rats results mainly from portasystemic shunting Gut 52 580 585
26. MA Leonis WF Balisteri 2008 Evaluation and management of end-stage liver disease in children Gastroenterology 134 1741 1751
27. Z Ackerman F Karmeli G Amir D Rachmilewitz 1996 Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension Liver 16 12 18
28. A Nakano T Kanda H Abe 1996 Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis J Gastroenterol Hepatol 11 1143 1154
29. A Cemborain I Castilla-Cortázar M García J Quiroga B Muguerza A Picardi S Santidrián J Prieto 1998 Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment J Hepatol 28 122 131
30. A Cemborain I Castilla-Cortázar M García B Muguerza G Delgado M Díaz-Sánchez A Picardi 2000 Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis J Physiol Biochem 56 91 99
31. MM Guichelaar M Malinchoc J Sibonga BL Clarke JE Hay 2002 Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry Hepatology 36 895 903
32. SL Elkin S Vedi S Bord NJ Garrahan ME Hodson JE Compston 2002 Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis Am J Respir Crit Care Med 166 1470 1474
33. PI Croucher S Vedi RJ Motley NJ Garrahan MR Stanton JE Compston 1993 Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease Osteoporos Int 3 236 241
34. TL McCarthy M Centrella 2001 Local IGF-I expression and bone formation Growth Horm IGF Research 11 213 219
35. MC Blomsma RJ Knegt RPFR Dullaart PL Jansen 1997 Insulin-like growth factor-I in liver cirrhosis J Hepatol 27 1133 1138
36. RW Gasser 2008 Cholestasis and metabolic bone disease-a clinical review Wien Med Wochenschr 158 553 557
37. MR Benedict MJ Lu JR Florini J Woo RA Richman 1994 The differential regulation of insulin-like growth factor (IGF) binding proteins by IGF-I during the life span of the rat J Gerontol 49 B215 B223
38. CJ Rosen HP Dimai D Vereault LR Donahue WG Beamer J Farley S Linkhart T Linkhart S Mohan DJ Baylink 1997 Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities Bone 21 217 223
39. N Guanabens A Pares I Ros L Alvarez F Pons L Caballeria A Monegal MJ Martinez de Osaba M Roca P Peris J Rodes 2003 Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis Am J Gastroenterol 98 2268 2274
40. R Dresner-Pollak Y Gabet A Steimatzky G Hamdani I Bab Z Ackerman M Weinreb 2008 Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats Gastroenterology 134 259 267
41. C Levy DM Harnois P Angulo R Jorgensen KD Lindor 2005 Raloxifene improves bone mass in osteopenic woman with primary biliary cirrhosis: results of a pilot study Liver Int 25 117 121
42. XZ Wang ZX Chen LJ Zhang YX Chen D Li FL Chen YH Huang 2003 Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis World J Gastroenterol 9 1287 1291
43. P Onori D Alvaro A Floreani MG Mancino A Franchitto M Guido G Carpino A de Santis M Angelico AF Attili E Gaudio 2007 Activation of the IGF 1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis J Histochem Cytochem 55 327 334
44. D Alvaro VD Metalli G Alpini P Onori A Franchitto B Barbaro SS Glaser H Francis A Cantafora I Blotta AF Attili E Gaudio 2005 The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis J Hepatol 43 875 883
45. JC Bucuvalas JA Horn J Slusher MP Alfaro SD Chernausek 1996 Growth hormone insensitivity in children with biliary atresia J Pediatr Gastroenterol Nutr 23 135 140
46. RC Cuneo PE Hickman JD Wallace BT Teh G Ward JD Veldhuis MJ Waters 1995 Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease Clin Endocrinol (Oxf) 43 265 275
47. A Picardi UV Gentilucci EM Zardi D Caccavo T Petitti S Manfrini P Pozzilli A Afeltra 2003 TNF-alpha and growth hormone resistance in patients with chronic liver disease J Interferon Cytokine Res 23 229 235
48. N Assy Y Pruzansky D Gaitini ZS Orr Z Hochberg Y Baruch 2008 Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction J Hepatol 49 34 42
49. TC Chang JJ Lin SC Yu TJ Chang 1990 Absence of growth hormone receptor in hepatocellular carcinoma and cirrhotic liver Hepatology 11 123 126
50. AJ Donaghy PJ Delhanty KK Ho R Williams RC Baxter 2002 Regulation of the growth hormone receptor/binding protein, insulinlike growth factor ternary complex system in human cirrhosis J Hepatol 36 751 758